Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Importance: Proton pump inhibitors (PPIs) or histamine-2 receptor blockers (H2RBs) are often prescribed for patients as stress ulcer prophylaxis drugs in the intensive care unit (ICU). The comparative effect of these drugs on mortality is unknown. Objective: To compare in-hospital mortality rates using PPIs vs H2RBs for stress ulcer prophylaxis. Design, Setting, and Participants: Cluster crossover randomized clinical trial conducted at 50 ICUs in 5 countries between August 2016 and January 2019. Patients requiring invasive mechanical ventilation within 24 hours of ICU admission were followed up for 90 days at the hospital. Interventions: Two stress ulcer prophylaxis strategies were compared (preferential use with PPIs vs preferential use with H2RBs). Each ICU used each strategy sequentially for 6 months in random order; 25 ICUs were randomized to the sequence with use of PPIs and then use of H2RBs and 25 ICUs were randomized to the sequence with use of H2RBs and then use of PPIs (13 436 patients randomized by site to PPIs and 13 392 randomized by site to H2RBs). Main Outcomes and Measures: The primary outcome was all-cause mortality within 90 days during index hospitalization. Secondary outcomes were clinically important upper gastrointestinal bleeding, Clostridioides difficile infection, and ICU and hospital lengths of stay. Results: Among 26 982 patients who were randomized, 154 opted out, and 26 828 were analyzed (mean [SD] age, 58 [17.0] years; 9691 [36.1%] were women). There were 26 771 patients (99.2%) included in the mortality analysis; 2459 of 13 415 patients (18.3%) in the PPI group died at the hospital by day 90 and 2333 of 13 356 patients (17.5%) in the H2RB group died at the hospital by day 90 (risk ratio, 1.05 [95% CI, 1.00 to 1.10]; absolute risk difference, 0.93 percentage points [95% CI, -0.01 to 1.88] percentage points; P = .054). An estimated 4.1% of patients randomized by ICU site to PPIs actually received H2RBs and an estimated 20.1% of patients randomized by ICU site to H2RBs actually received PPIs. Clinically important upper gastrointestinal bleeding occurred in 1.3% of the PPI group and 1.8% of the H2RB group (risk ratio, 0.73 [95% CI, 0.57 to 0.92]; absolute risk difference, -0.51 percentage points [95% CI, -0.90 to -0.12 percentage points]; P = .009). Rates of Clostridioides difficile infection and ICU and hospital lengths of stay were not significantly different by treatment group. One adverse event (an allergic reaction) was reported in 1 patient in the PPI group. Conclusions and Relevance: Among ICU patients requiring mechanical ventilation, a strategy of stress ulcer prophylaxis with use of proton pump inhibitors vs histamine-2 receptor blockers resulted in hospital mortality rates of 18.3% vs 17.5%, respectively, a difference that did not reach the significance threshold. However, study interpretation may be limited by crossover in the use of the assigned medication. Trial Registration: anzctr.org.au Identifier: ACTRN12616000481471.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
Vincent, J.-L., Marshall, J. C., Ñamendys-Silva, S. A., François, B., Martin-Loeches, I., Lipman, J., Reinhart, K., Antonelli, M., Pickkers, P., Njimi, H., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70061-x · Cited by 1,252
Higgins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU
Krag, M., Marker, S., Perner, A., Wetterslev, J., Wise, M. P., Schefold, J. C., Keus, F., Guttormsen, A. B., Bendel, S., Borthwick, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714919 · Cited by 344
Kedika, R. R., Souza, R. F., & Spechler, S. J. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0951-9 · Cited by 324
Begg, M. D., & Parides, M. K. (2003) · Statistics in Medicine · doi:10.1002/sim.1524 · Cited by 300
co-authors, T. S.-I., Krag, M., Perner, A., Wetterslev, J., Wise, M. P., Borthwick, M., Bendel, S., McArthur, C., Cook, D., Nielsen, N., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3725-1 · Cited by 272 · cited 3×
“Preplanned analyses assessed heterogeneity of treatment effects on the primary and secondary outcomes for the following subgroups: (1) patients admitted to the ICU after cardiac surgery vs any other reason, (2) patients admitted after emergency vs elective surgery, and (3) patients by geographic region.”
BackgroundSelf-citationLocalio, A. R., Margolis, D. J., & Berlin, J. A. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.12.001 · Cited by 259
Alhazzani, W., Alenezi, F., Jaeschke, R. Z., Moayyedi, P., & Cook, D. J. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182758734 · Cited by 258
MacLaren, R., Reynolds, P. M., & Allen, R. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.14673 · Cited by 238
Nosocomial Pneumonia Risk and Stress Ulcer Prophylaxis
Miano, T. A., Reichert, M. G., Houle, T. T., MacGregor, D. A., Kincaid, E. H., & Bowton, D. L. (2009) · CHEST Journal · doi:10.1378/chest.08-1634 · Cited by 107
Cited by
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Registry-based randomised controlled trials: conduct, advantages and challenges—a systematic review
Shiely, F., O Shea, N., Murphy, E., & Eustace, J. (2024) · Trials · doi:10.1186/s13063-024-08209-3 · Cited by 24
Metadata
- Authors
- The PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, A. H. S. C. C. S. C. N., Young, P. J., Bagshaw, S. M., Forbes, A. B., Nichol, A. D., Wright, S. E., Bailey, M., Bellomo, R., Beasley, R., Brickell, K., Eastwood, G. M., Gattas, D. J., van Haren, F., Litton, E., Mackle, D. M., McArthur, C. J., McGuinness, S. P., Mouncey, P. R., Navarra, L., Opgenorth, D., Pilcher, D., Saxena, M. K., Webb, S. A., Wiley, D., & Rowan, K. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2020-02-18
- Volume
- 323
- Issue
- 7
- Pages
- 616
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2999734656
- Cited by
- 233
- References
- 19
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2019.22190
- The paper
- The PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, A. H. S. C. C. S. C. N., Young, P. J., Bagshaw, S. M., Forbes, A. B., Nichol, A. D., Wright, S. E., Bailey, M., Bellomo, R., Beasley, R., Brickell, K., Eastwood, G. M., Gattas, D. J., van Haren, F., Litton, E., Mackle, D. M., McArthur, C. J., McGuinness, S. P., Mouncey, P. R., Navarra, L., . . . Rowan, K. M. (2020). Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2019.22190
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.